DexCom Total Assets 2010-2024 | DXCM

DexCom total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • DexCom total assets for the quarter ending September 30, 2024 were $6.354B, a 3.67% decline year-over-year.
  • DexCom total assets for 2023 were $6.265B, a 16.19% increase from 2022.
  • DexCom total assets for 2022 were $5.392B, a 9.29% increase from 2021.
  • DexCom total assets for 2021 were $4.933B, a 14.98% increase from 2020.
DexCom Annual Total Assets
(Millions of US $)
2023 $6,265
2022 $5,392
2021 $4,933
2020 $4,291
2019 $2,395
2018 $1,916
2017 $904
2016 $403
2015 $292
2014 $185
2013 $123
2012 $106
2011 $121
2010 $77
2009 $47
DexCom Quarterly Total Assets
(Millions of US $)
2024-09-30 $6,354
2024-06-30 $6,799
2024-03-31 $6,482
2023-12-31 $6,265
2023-09-30 $6,596
2023-06-30 $6,821
2023-03-31 $5,516
2022-12-31 $5,392
2022-09-30 $4,899
2022-06-30 $5,217
2022-03-31 $5,057
2021-12-31 $4,933
2021-09-30 $4,776
2021-06-30 $4,504
2021-03-31 $4,390
2020-12-31 $4,291
2020-09-30 $3,833
2020-06-30 $3,522
2020-03-31 $2,448
2019-12-31 $2,395
2019-09-30 $2,186
2019-06-30 $2,066
2019-03-31 $1,974
2018-12-31 $1,916
2018-09-30 $1,114
2018-06-30 $1,008
2018-03-31 $897
2017-12-31 $904
2017-09-30 $843
2017-06-30 $796
2017-03-31 $467
2016-12-31 $403
2016-09-30 $362
2016-06-30 $333
2016-03-31 $299
2015-12-31 $292
2015-09-30 $257
2015-06-30 $218
2015-03-31 $189
2014-12-31 $185
2014-09-30 $159
2014-06-30 $140
2014-03-31 $125
2013-12-31 $123
2013-09-30 $110
2013-06-30 $102
2013-03-31 $99
2012-12-31 $106
2012-09-30 $103
2012-06-30 $111
2012-03-31 $118
2011-12-31 $121
2011-09-30 $129
2011-06-30 $136
2011-03-31 $67
2010-12-31 $77
2010-09-30 $54
2010-06-30 $61
2010-03-31 $68
2009-12-31 $47
2009-09-30 $54
2009-06-30 $65
2009-03-31 $78
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $31.263B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.449B 24.45
Intuitive Surgical (ISRG) United States $186.791B 97.66
Edwards Lifesciences (EW) United States $44.123B 28.02
Alcon (ALC) Switzerland $41.807B 27.97
IQVIA Holdings (IQV) United States $35.805B 19.73
IDEXX Laboratories (IDXX) United States $33.758B 39.76
Waters (WAT) United States $21.860B 32.32
STERIS (STE) Ireland $20.481B 23.58
SONOVA HOLDING (SONVY) Switzerland $19.736B 0.00
Hologic (HOLX) United States $16.260B 17.56
Fresenius Medical Care AG KGaA (FMS) Germany $13.386B 13.74
Sysmex ADR (SSMXY) Japan $11.751B 0.00
Globus Medical (GMED) United States $11.252B 28.49
Penumbra (PEN) United States $9.308B 91.18
Masimo (MASI) United States $9.076B 43.92
Glaukos (GKOS) United States $8.319B 0.00
Teleflex (TFX) United States $8.274B 13.20
Integer Holdings (ITGR) United States $4.484B 25.41
PROCEPT BioRobotics (PRCT) United States $4.236B 0.00
Inari Medical (NARI) United States $3.246B 0.00
Veracyte (VCYT) United States $3.169B 95.09
LivaNova (LIVN) United Kingdom $2.584B 14.92
Nihon Kohden (NHNKY) Japan $2.392B 18.17
Tandem Diabetes Care (TNDM) United States $2.358B 0.00
Elekta AB (EKTAY) Sweden $2.084B 18.74
TransMedics (TMDX) United States $2.071B 65.64
Integra LifeSciences Holdings (IART) United States $1.682B 8.79
RxSight (RXST) United States $1.357B 0.00
Alphatec Holdings (ATEC) United States $1.326B 0.00
Artivion (AORT) United States $1.194B 79.11
Pulse Biosciences (PLSE) United States $1.106B 0.00
OPKO Health (OPK) United States $1.051B 0.00
Paragon 28 (FNA) United States $0.840B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.739B 12.56
Mesa Laboratories (MLAB) United States $0.717B 16.91
IRadimed (IRMD) United States $0.693B 37.43
AxoGen (AXGN) United States $0.688B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.666B 0.00
Semler Scientific (SMLR) United States $0.573B 30.14
SiBone (SIBN) United States $0.556B 0.00
OrthoPediatrics (KIDS) United States $0.542B 0.00
Pacific Biosciences Of California (PACB) United States $0.540B 0.00
Treace Medical Concepts (TMCI) United States $0.434B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.408B 22.08
AngioDynamics (ANGO) United States $0.361B 0.00
Delcath Systems (DCTH) United States $0.352B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.294B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Inogen (INGN) United States $0.202B 0.00
Accuray (ARAY) United States $0.186B 0.00
KORU Medical Systems (KRMD) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.181B 0.00
Nevro (NVRO) United States $0.142B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
Spectral Diagnostics (EDTXF) Canada $0.091B 0.00
LENSAR (LNSR) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
908 Devices (MASS) United States $0.072B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.064B 0.00
WORK Medical Technology Group (WOK) China $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Neuronetics (STIM) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.023B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.009B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00